Performance evaluation of a particle agglutination test for antibody to human immunodeficiency virus 1: comparison with enzyme immunoassay.

A performance evaluation of a particle agglutination test (PAT), manufactured by Fujirebio Inc., Japan (Serodia-HIV), for antibody to human immunodeficiency virus type-1 (anti-HIV-1) was carried out and compared with a currently available enzyme immunoassay (EIA), manufactured by Genetic Systems Corp., USA, (HIV-1/HIV-2 EIA).

Immunization of hospital personnel with low-dose intradermal hepatitis B vaccine.

Hepatitis B (HB) is an occupational hazard among health care workers. The only hope of control is by the use of vaccines. We evaluated the efficacy of HB vaccine, given intradermally to 304 hospital staff members.

Hepatitis B virus infection in hospital personnel.

Background: Healthcare workers are known to be prone to infection with the hepatitis B virus. We did this study, as there are only a few reports from India on the prevalence of this infection among hospital personnel, so that a rational and effective immunization policy could be evolved.

Method: Eight hundred and sixty-three hospital employees including doctors, nurses, technicians, office workers, orderlies and other ancillary staff were screened by ELISA for both hepatitis B surface antigen and its antibody as indicators of prior infection.

Prevalence of hepatitis B surface antigen & its subtypes in high risk group subjects & voluntary blood donors in Bombay.

HBsAg positive subjects belonging to high risk groups and voluntary blood donors were analysed for prevalence of HBsAg among various groups of subjects for ascertaining the carrier status among the voluntary blood donors, HBsAg subtype distribution, and association of HBsAg with blood groups and caste or religion. The prevalence of HBsAg varied from 2.02 per cent in voluntary blood donors to 58.